Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

At-home care for breast cancer patients using an e-health app

Official title: At-home Breast Oncology Care Delivered With E-health Solutions The ABODE Study

Run by University Health Network, Toronto · NCT05989477 · Data updated 2026-11-12

This study is testing whether using a special app for breast cancer patients, along with their regular care, can help them feel more involved in their treatment compared to just receiving standard care alone.

More Patient Reported Outcome Measures trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment200 (estimated)
SponsorUniversity Health Network, Toronto
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedJune 22, 2023
Main results expectedDecember 2027
Study endsDecember 2028
Registry record updatedOctober 30, 2026
Trial IDNCT05989477 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are females aged 18 and older, diagnosed with primary invasive breast cancer who will undergo surgery as their first treatment step.

Probably not a fit

Patients with non-operable or metastatic breast cancer, or those with significant hearing or visual challenges, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates a multi-dimensional remote eHealth solution designed for newly diagnosed breast cancer patients. Participants will be randomly assigned to either use a Breast Cancer Treatment Application (app) alongside standard care or receive standard care alone. The app facilitates virtual consultations, provides educational materials, and collects patient-reported outcome measures (PROMs). The primary objective is to assess changes in patient activation over one year, while secondary outcomes will include additional PROMs and data from wearable devices.

Why it matters

Potential benefit: If successful, this approach could enhance patient engagement and self-management in breast cancer care.

How similar studies have gone: Other studies have shown promise in using e-health solutions for patient engagement, indicating potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Females (assigned female at birth)\*
* Diagnosed with first, primary invasive BC
* Must have surgery as their first step in treatment pathway
* Age≥18
* Access to an electronic device with connection to the internet
* A valid email address
* Can communicate in English \*Since BC risk is sex-related and based on physiological values, our inclusion criteria are based on sex (not gender)

Exclusion criteria:

* Males (assigned male at birth), as BC surgical treatment options and experiences are different
* Diagnosed with non-operable breast cancer
* Stage 4/metastatic (whether determined at diagnosis or during surgery)
* Those with hearing or visual challenges
* Neo-adjuvant chemotherapy
* Should not be enrolled in any other UHN study using an e-Health application
* Breast cancer surgery is scheduled for less 5 business days after enrollment

Where it's running

  • Tulin Cil
    Toronto, Ontario, Canada
    Recruiting

Study contacts

  • Principal investigator: Tulin Cil, MD, MEd — University Health Network, Toronto
  • Study coordinator: Tulin Cil, MD, MEd
  • Email: tulin.cil@uhn.ca
  • Phone: 416-946-4507

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.